The Acessa® Laparoscopic Radiofrequency Ablation procedure continues to gain momentum as a safe and effective minimally invasive solution for women suffering from symptomatic uterine fibroids. If you don’t know what all the buzz is about, here’s a quick rundown on what you should know about this groundbreaking procedure.
A different approach
The Acessa procedure uses controlled radio frequency energy (heat) to cause coagulative necrosis of the fibroid tissue. The treated tissue softens and shrinks over time, allowing fibroid symptoms to resolve without difficult and time-consuming uterine suturing.1
Targets more fibroids
Unlike many alternative treatments, the Acessa procedure allows for a full view of the pelvic anatomy by simultaneously displaying the lap camera view and the ultrasound view in real time. This means you can easily locate and target nearly all types of fibroids—yes, even intramural.2
Clinically proven, patient approved
The Acessa procedure is a safe and effective treatment for symptomatic uterine fibroids, as supported by clinical data demonstrating significantly reduced fibroid volume across a broad range of fibroid types, favorable reintervention rates, and significant improvements in fibroid-related quality of life.3
The procedure also has a 94% patient satisfaction rate and a 98% patient-to-patient recommendation rate. The Acessa procedure provides hope for patients with difficult-to-treat fibroids who are seeking a solution that will not require invasive surgery.2
Key takeaways
The Acessa procedure:
- Offers optimized technology for more complete fibroid treatment
- Provides relief with low reintervention
- Allows you to care for more patients by offering more uterine-sparing options
Plus, Hologic provides unparalleled support from start to finish as you integrate the Acessa procedure into your practice.
To learn more about the Acessa procedure, contact your sales representative or learn more here:
https://GynSurgicalSolutions.com/hcp/laparoscopy/acessa-provu-system/
Important Safety Information
The Acessa ProVu system is indicated for use in percutaneous, laparoscopic coagulation and ablation of soft tissue, including treatment of symptomatic uterine fibroids under laparoscopic ultrasound guidance. The Acessa ProVu system is contraindicated for patients who are not candidates for laparoscopic surgery and/or patients with a uterus adherent to pelvic tissue or viscera. The Acessa ProVu system’s guidance system is not intended for diagnostic use. Please read all instructions for use of the Acessa ProVu system prior to its use. Safe and effective electrosurgery is dependent not only on equipment design but also on factors under control of the operator. Rare but serious risks include, but are not limited to, infection, injury to adjacent structures, blood loss and complications related to laparoscopy and/or general anesthesia. Insufficient data exists on which to evaluate the safety and effectiveness of the Acessa ProVu system in women who plan future pregnancy, therefore the Acessa ProVu system is not recommended for women who are planning future pregnancy.
References:
- Havryliuk Y, Setton R, Carlow JJ, Shaktman BD. Symptomatic fibroid management: systematic review of the literature. JSLS. 2017;21(3): e2017.00041. doi:10.4293/JSLS.2017.00041
- Chudnoff SG, Berman JM, Levine DJ, Harris M, Guido Rs, Banks E. Outpatient procedure for the treatment and relief of symptomatic uterine myomas. Obstet Gynecol. 2013;121(5):1075-1082. doi:10.1097/AOG.0b013e31828b7962
- Bradley LD, Pasic RP, Miller LE. Clinical performance of radiofrequency ablation for treatment of uterine fibroids: systematic review and meta-analysis of prospective studies. J Laparoendosc Adv Surg Tech A. 2019;29(12):1507-1517. doi:10.1089/lap.2019.0550